Lupus-like syndrome attributable to anti-tumor necrosis factor alpha therapy in 14 patients during an 8-year period at Mayo Clinic
about
Safety and immunotoxicity assessment of immunomodulatory monoclonal antibodiesAdverse events in IBD: to stop or continue immune suppressant and biologic treatmentTumor necrosis factor-alpha antagonist etanercept decreases blood pressure and protects the kidney in a mouse model of systemic lupus erythematosusMechanisms of tumor necrosis factor α antagonist-induced lupus in a murine model.Roles of pro- and anti-inflammatory cytokines in the pathogenesis of SLEAnti-Tumor Necrosis Factor-α Induced Systemic Lupus Erythematosus().TNFα inhibitor induced lupus-like syndrome (TAILS) in a patient with IBD.Vasculitis associated with tumor necrosis factor-α inhibitorsFamilial secondary hyperhidrosis associated with tumor necrosis factor-alpha inhibitor treatment.Hepatitis and Lupus-Like Syndrome during Infliximab Therapy for Psoriasis.Tumor necrosis factor-alpha as a potential therapeutic target in idiopathic inflammatory myopathies.TNF alpha antagonist-induced lupus-like syndrome: report and review of the literature with implications for treatment with alternative TNF alpha antagonists.Drug-induced lupus anticoagulants and antiphospholipid antibodies.A Patient with Psoriatic Arthritis Imaged with FDG-PET/CT Demonstrated an Unusual Imaging Pattern with Muscle and Fascia Involvement: A Case Report.Suppression of mycobacterium tuberculosis induced reactive oxygen species and tumor necrosis factor-alpha activity in human monocytes of systemic lupus erythematosus patients by reduced glutathione.Adalimumab-associated bullous pemphigoid in a patient with ulcerative colitisAnti-TNF-α and hydralazine drug-induced lupus.Systemic lupus erythematosus in Crohn's disease: drug-induced or idiopathic?Infliximab-Induced Lupus: A Case Report.Stevens-Johnsons syndrome or drug-induced lupus - a clinical dilemma: A case report and review of the literature.
P2860
Q33895804-27539834-36EA-46F3-BB41-728E0F9B0874Q34073191-B68B11D1-3876-4FB9-B909-34CDDAFE8F19Q34339359-326B3040-8F50-4121-99BA-B241E46DA18CQ34790990-F27526B6-4A31-40C3-AF1B-A087574F9EFFQ35829864-9C0D0E84-2931-40C2-AC52-90607EAA6B36Q36418745-E0C84977-B0D6-4317-A709-E9803F3D233AQ36453770-A3C9A06C-0FA0-4CC7-8EDB-F0CA36CB05DEQ36513081-CCC61DFA-E790-4DC3-89B8-A8189D05B4C0Q36733728-05AFDE07-33FC-4EC8-B546-4804DF98F54DQ37151335-E8675639-73CC-4DB4-991F-0138D542B7C3Q37831189-C9CAF924-5361-4EDD-A65D-4D30CFFF7CB1Q37867162-C8529220-DBE8-4CEB-91A0-FCFC45326C51Q37967416-8AF0F839-0864-4BA5-8C69-840025787F0AQ40219226-6BDFA570-BBA0-49B7-AE4F-B09B9DF5F82FQ40295348-32536DB9-AF18-4BCB-9DAB-A385CC198D19Q41064114-FD9B5E99-46E2-4D08-B44E-23752F4CB832Q41825316-A665920F-9842-4E4E-A9A7-DEEE19AF3EE1Q41832003-2C4EE85E-7CCE-4366-B556-89D3F9F37CA7Q55019792-562EBEEF-5290-4BDA-A8E3-F6A1C4390241Q55256134-0CB44CF1-1EA7-49ED-95CC-8D26D0E17714
P2860
Lupus-like syndrome attributable to anti-tumor necrosis factor alpha therapy in 14 patients during an 8-year period at Mayo Clinic
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Lupus-like syndrome attributab ...... n 8-year period at Mayo Clinic
@en
Lupus-like syndrome attributab ...... 8-year period at Mayo Clinic.
@nl
type
label
Lupus-like syndrome attributab ...... n 8-year period at Mayo Clinic
@en
Lupus-like syndrome attributab ...... 8-year period at Mayo Clinic.
@nl
prefLabel
Lupus-like syndrome attributab ...... n 8-year period at Mayo Clinic
@en
Lupus-like syndrome attributab ...... 8-year period at Mayo Clinic.
@nl
P2860
P356
P1476
Lupus-like syndrome attributab ...... n 8-year period at Mayo Clinic
@en
P2093
David A Wetter
Mark D P Davis
P2860
P304
P356
10.4065/84.11.979
P407
P577
2009-11-01T00:00:00Z